Nanoscale Magneto-mechanical-genetics of Deep Brain Neurons Reversing Motor Deficits in Parkinsonian Mice
Source abstract
Abstract
Here, we introduce the magneto-mechanical-genetic (MMG)-driven wireless deep brain stimulation (DBS) using magnetic nanostructures for therapeutic benefits in the mouse model of Parkinson's disease (PD). Electrical DBS of the subthalamic nucleus (STN) is an effective therapy for mitigating Parkinson's motor symptoms. However, its broader application is hampered by the requirement for implanted electrodes and the lack of anatomical and cellular specificity. Using the nanoscale magnetic force actuators (m-Torquer), which deliver torque force under rotating magnetic fields to activate pre-encoded Piezo1 ion channels on target neurons, our system enables wireless and STN-specific DBS without implants, addressing key unmet challenges in the DBS field. In both late- and early-stage PD mice, MMG-DBS significantly improved locomotor activity and motor balance by 2-fold compared to untreated PD mice. Moreover, MMG-DBS enabled sustained therapeutic effects. This approach provides a non-invasive and implant-free DBS with cellular targeting capability for the effective treatment of Parkinsonian symptoms.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Neurological disorders and treatments · Neuroscience and Neural Engineering · Advanced Sensor and Energy Harvesting Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center for Nanomedicine, Institute for Basic Science, Seoul 03722, Republic of Korea
Department of Nano Biomedical Engineering, Advanced Science Institute, Yonsei University, Seoul 03722, Republic of Korea
Department of Neurology, Yonsei University College of Medicine, Seoul 03722, South Korea
Department of Biomedical Science, Yonsei University College of Medicine, Seoul 03722, South Korea
Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea
Funding
Institute for Basic Science
References (35)
Show source-provided references
1. 10.1016/S0140-6736(21)00218-X10.1016/S0140-6736(21)00218-X ↗
2. 10.1016/j.neuron.2019.03.00410.1016/j.neuron.2019.03.004 ↗
3. 10.1038/s41582-019-0145-910.1038/s41582-019-0145-9 ↗
4. 10.1136/jnnp.2003.03129410.1136/jnnp.2003.031294 ↗
5. 10.1056/NEJMct120807010.1056/NEJMct1208070 ↗
6. 10.1016/j.clinph.2005.10.00710.1016/j.clinph.2005.10.007 ↗
7. 10.1177/030006051985674710.1177/0300060519856747 ↗
8. 10.1038/s41582-018-0128-210.1038/s41582-018-0128-2 ↗
9. 10.1016/j.cortex.2009.02.00710.1016/j.cortex.2009.02.007 ↗
10. 10.1136/jnnp.2009.20255610.1136/jnnp.2009.202556 ↗
11. 10.1016/j.nicl.2019.10176810.1016/j.nicl.2019.101768 ↗
12. 10.1007/s00702-020-02255-210.1007/s00702-020-02255-2 ↗
13. 10.15412/J.BCN.0307030310.15412/J.BCN.03070303 ↗
14. 10.1056/NEJMoa201631110.1056/NEJMoa2016311 ↗
15. 10.1016/j.tics.2011.10.00310.1016/j.tics.2011.10.003 ↗
16. 10.1038/s41467-020-16046-610.1038/s41467-020-16046-6 ↗
17. 10.1038/s41551-022-00965-410.1038/s41551-022-00965-4 ↗
18. 10.1126/science.aaq114410.1126/science.aaq1144 ↗
19. 10.1038/s41563-020-00896-y10.1038/s41563-020-00896-y ↗
20. 10.1021/acs.nanolett.2c0231410.1021/acs.nanolett.2c02314 ↗
21. 10.1038/s41467-021-25837-410.1038/s41467-021-25837-4 ↗
22. 10.1007/BF0303356510.1007/BF03033565 ↗
23. 10.1186/s12868-019-0487-710.1186/s12868-019-0487-7 ↗
24. 10.1016/j.bbr.2005.02.02310.1016/j.bbr.2005.02.023 ↗
25. 10.1016/j.neuint.2018.11.00510.1016/j.neuint.2018.11.005 ↗
26. 10.1016/j.parkreldis.2015.11.01010.1016/j.parkreldis.2015.11.010 ↗
27. 10.1212/WNL.60.1.7810.1212/WNL.60.1.78 ↗
28. 10.1006/exnr.2002.789110.1006/exnr.2002.7891 ↗
29. 10.1212/WNL.000000000000994610.1212/WNL.0000000000009946 ↗
30. 10.1111/ejn.1245910.1111/ejn.12459 ↗
31. 10.1002/syn.1027410.1002/syn.10274 ↗
32. 10.1038/s41583-022-00624-210.1038/s41583-022-00624-2 ↗
33. 10.34133/research.013010.34133/research.0130 ↗
34. 10.1016/j.neuron.2022.07.01010.1016/j.neuron.2022.07.010 ↗
35. 10.1523/JNEUROSCI.3071-19.202010.1523/JNEUROSCI.3071-19.2020 ↗